These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 26478186)
1. Effect of β-cyclodextrin on the internalization of nanoparticles into intestine epithelial cells. García-González L; Yépez-Mulía L; Ganem A Eur J Pharm Sci; 2016 Jan; 81():113-8. PubMed ID: 26478186 [TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line. Gorjikhah F; Azizi Jalalian F; Salehi R; Panahi Y; Hasanzadeh A; Alizadeh E; Akbarzadeh A; Davaran S Artif Cells Nanomed Biotechnol; 2017 May; 45(3):432-440. PubMed ID: 27002986 [TBL] [Abstract][Full Text] [Related]
3. Development of PLGA nanoparticles loaded with clofazimine for oral delivery: Assessment of formulation variables and intestinal permeability. Chaves LL; Costa Lima SA; Vieira ACC; Barreiros L; Segundo MA; Ferreira D; Sarmento B; Reis S Eur J Pharm Sci; 2018 Jan; 112():28-37. PubMed ID: 29122712 [TBL] [Abstract][Full Text] [Related]
4. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Roger E; Kalscheuer S; Kirtane A; Guru BR; Grill AE; Whittum-Hudson J; Panyam J Mol Pharm; 2012 Jul; 9(7):2103-10. PubMed ID: 22670575 [TBL] [Abstract][Full Text] [Related]
5. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization. Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384 [TBL] [Abstract][Full Text] [Related]
6. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208 [TBL] [Abstract][Full Text] [Related]
7. Development of polymeric and cyclodextrin nanoparticles for camptothecin delivery. Cirpanli Y; Bilensoy E; Dogan AL; Calis S J Control Release; 2010 Nov; 148(1):e21-3. PubMed ID: 21529600 [No Abstract] [Full Text] [Related]
8. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
9. Nanomaterial-dependent immunoregulation of dendritic cells and its effects on biological activities of contraceptive nanovaccines. Xu P; Tang S; Jiang L; Yang L; Zhang D; Feng S; Zhao T; Dong Y; He W; Wang R; Zhang J; Liang Z J Control Release; 2016 Mar; 225():252-68. PubMed ID: 26826303 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
11. The effect of HPβCD on Cyclosporine A in-vitro release from PLGA nanoparticles. Hermans K; Weyenberg W; Ludwig A J Control Release; 2010 Nov; 148(1):e40-1. PubMed ID: 21529614 [No Abstract] [Full Text] [Related]
12. [Transport of PLGA nanoparticles across Caco-2/HT29-MTX co-cultured cells]. Wen Z; Li G; Lin DH; Wang JT; Qin LF; Guo GP Yao Xue Xue Bao; 2013 Dec; 48(12):1829-35. PubMed ID: 24689242 [TBL] [Abstract][Full Text] [Related]
13. Enhanced uptake and transport of PLGA-modified nanoparticles in cervical cancer. Sims LB; Curtis LT; Frieboes HB; Steinbach-Rankins JM J Nanobiotechnology; 2016 Apr; 14():33. PubMed ID: 27102372 [TBL] [Abstract][Full Text] [Related]
14. Development of hematin conjugated PLGA nanoparticle for selective cancer targeting. Amin ML; Kim D; Kim S Eur J Pharm Sci; 2016 Aug; 91():138-43. PubMed ID: 27260086 [TBL] [Abstract][Full Text] [Related]
15. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification. Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034 [TBL] [Abstract][Full Text] [Related]
16. Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles. Liu L; Ma P; Wang H; Zhang C; Sun H; Wang C; Song C; Leng X; Kong D; Ma G J Control Release; 2016 Mar; 225():230-9. PubMed ID: 26826307 [TBL] [Abstract][Full Text] [Related]
17. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations. Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610 [TBL] [Abstract][Full Text] [Related]
18. Development of innovative paclitaxel-loaded small PLGA nanoparticles: study of their antiproliferative activity and their molecular interactions on prostatic cancer cells. Le Broc-Ryckewaert D; Carpentier R; Lipka E; Daher S; Vaccher C; Betbeder D; Furman C Int J Pharm; 2013 Oct; 454(2):712-9. PubMed ID: 23707251 [TBL] [Abstract][Full Text] [Related]
19. Combined effect of PLGA and curcumin on wound healing activity. Chereddy KK; Coco R; Memvanga PB; Ucakar B; des Rieux A; Vandermeulen G; Préat V J Control Release; 2013 Oct; 171(2):208-15. PubMed ID: 23891622 [TBL] [Abstract][Full Text] [Related]